Depending on the drug characteristics and client needs, standard study protocols can be designed or customized to conduct single-dose toxicity studies of drugs under GLP conditions that meet the regulatory and technical requirements of ICH, NMPA, and FDA, thereby satisfying the requirements for applying for clinical trials or marketing authorization.